These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9602955)

  • 1. Effect of increasing gastric pH with famotidine on the absorption and oral pharmacokinetics of the inotropic agent vesnarinone.
    Koneru B; Cowart DT; Noorisa M; Kisicki J; Bramer SL
    J Clin Pharmacol; 1998 May; 38(5):429-32. PubMed ID: 9602955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of disulfiram-mediated CYP2E1 inhibition on the disposition of vesnarinone.
    Frye RF; Tammara B; Cowart TD; Bramer SL
    J Clin Pharmacol; 1999 Nov; 39(11):1177-83. PubMed ID: 10579149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of food and gastric pH on the bioavailability of grepafloxacin.
    Efthymiopoulos C; Bramer SL; Maroli A
    Clin Pharmacokinet; 1997; 33 Suppl 1():18-24. PubMed ID: 9433652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
    Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
    J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.
    Stass H; Böttcher MF; Ochmann K
    Clin Pharmacokinet; 2001; 40 Suppl 1():39-48. PubMed ID: 11352441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the pharmacokinetic interaction between cimetidine or famotidine and cyclosporine in healthy men.
    Shaefer MS; Rossi SJ; McGuire TR; Schaaf LJ; Collier DS; Stratta RJ
    Ann Pharmacother; 1995 Nov; 29(11):1088-91. PubMed ID: 8573949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
    Ikawa K; Shimatani T; Hayato S; Morikawa N; Tazuma S
    Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial.
    Feldman M
    JAMA; 1996 May; 275(18):1428-31. PubMed ID: 8618369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CYP3A inhibition on vesnarinone metabolism in humans.
    Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ
    Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects.
    Eley T; Luo FR; Agrawal S; Sanil A; Manning J; Li T; Blackwood-Chirchir A; Bertz R
    J Clin Pharmacol; 2009 Jun; 49(6):700-9. PubMed ID: 19395585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and efficacy of intravenous famotidine in adult cattle.
    Balcomb CC; Heller MC; Chigerwe M; Knych HK; Meyer AM
    J Vet Intern Med; 2018 May; 32(3):1283-1289. PubMed ID: 29572958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects.
    Suzuki T; Yamaguchi T; Odaka T; Kobayashi M; Seza A; Kouzu T; Yokosuka O
    Aliment Pharmacol Ther; 2008 Jan; 27(1):66-71. PubMed ID: 17922801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine.
    Shimatani T; Inoue M; Kuroiwa T; Xu J; Nakamura M; Tazuma S; Ikawa K; Morikawa N
    Dig Dis Sci; 2006 Jan; 51(1):114-20. PubMed ID: 16416222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of famotidine in children.
    James LP; Marshall JD; Heulitt MJ; Wells TG; Letzig L; Kearns GL
    J Clin Pharmacol; 1996 Jan; 36(1):48-54. PubMed ID: 8932543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption of oral mesalazine-containing preparations and the influence of famotidine on the absorption.
    Wiltink EH; Mulder CJ; Stolk LM; Rietbroek R; Verbeek C; Tytgat GN
    Scand J Gastroenterol; 1990 Jun; 25(6):579-84. PubMed ID: 2359989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies.
    Yeh KC; Chremos AN; Lin JH; Constanzer ML; Kanovsky SM; Hucker HB; Antonello J; Vlasses P; Ryan JR; Williams RL
    Biopharm Drug Dispos; 1987; 8(6):549-60. PubMed ID: 2892544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.